Ask AI
PROMISE US
PROMISE-US: Phase IV Noninterventional Registry Study Evaluating Long-term Efficacy/Durability of Ibalizumab + Other ARVs in People Living With MDR HIV

Released: March 03, 2026

Activity

Progress
1
Course Completed
Activity Information

Released: March 03, 2026